Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Tumor vascular area correlates with photosensitizer uptake: analysis of verteporfin microvascular delivery in the Dunning rat prostate tumor.

Zhou X, Chen B, Hoopes PJ, Hasan T, Pogue BW.

Photochem Photobiol. 2006 Sep-Oct;82(5):1348-57.

PMID:
17421078
2.

Analysis of effective molecular diffusion rates for verteporfin in subcutaneous versus orthotopic Dunning prostate tumors.

Zhou X, Pogue BW, Chen B, Hasan T.

Photochem Photobiol. 2004 Apr;79(4):323-31.

PMID:
15137508
3.

Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.

Chen B, Pogue BW, Zhou X, O'Hara JA, Solban N, Demidenko E, Hoopes PJ, Hasan T.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):720-7.

4.
5.

Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.

Chen B, Pogue BW, Hoopes PJ, Hasan T.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1216-26.

PMID:
15752904
6.
7.

Pretreatment photosensitizer dosimetry reduces variation in tumor response.

Zhou X, Pogue BW, Chen B, Demidenko E, Joshi R, Hoopes J, Hasan T.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1211-20.

PMID:
16504761
8.

Spatial heterogeneity and temporal kinetics of photosensitizer (AlPcS2) concentration in murine tumors RIF-1 and MTG-B.

Lee CC, Pogue BW, O'Hara JA, Wilmot CM, Strawbridge RR, Burke GC, Hoopes PJ.

Photochem Photobiol Sci. 2003 Feb;2(2):145-50.

PMID:
12664976
9.

Perfusion CT estimates photosensitizer uptake and biodistribution in a rabbit orthotopic pancreatic cancer model: a pilot study.

Elliott JT, Samkoe KS, Gunn JR, Stewart EE, Gardner TB, Tichauer KM, Lee TY, Hoopes PJ, Pereira SP, Hasan T, Pogue BW.

Acad Radiol. 2015 May;22(5):572-9. doi: 10.1016/j.acra.2014.12.014. Epub 2015 Feb 14.

10.

Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.

Chen B, Crane C, He C, Gondek D, Agharkar P, Savellano MD, Hoopes PJ, Pogue BW.

Int J Cancer. 2008 Aug 1;123(3):695-701. doi: 10.1002/ijc.23538.

11.

Clinical pharmacokinetics of verteporfin.

Houle JM, Strong A.

J Clin Pharmacol. 2002 May;42(5):547-57.

PMID:
12017349
12.

In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour.

Hamblin MR, Rajadhyaksha M, Momma T, Soukos NS, Hasan T.

Br J Cancer. 1999 Sep;81(2):261-8.

13.

Uptake of the photosensitizer benzoporphyrin derivative in human endometrium after topical application in vivo.

Hornung R, Fehr MK, Tromberg BJ, Major A, Krasieva TB, Berns MW, Tadir Y.

J Am Assoc Gynecol Laparosc. 1998 Nov;5(4):367-74.

PMID:
9782140
15.

Simple, reliable and fast spectrofluorometric method for determination of plasma Verteporfin (Visudyne) levels during photodynamic therapy for choroidal neovascularization.

Aquaron R, Forzano O, Murati JL, Fayet G, Aquaron C, Ridings B.

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):925-30. Erratum in: Cell Mol Biol (Noisy-le-grand). 2003 Feb;49(1):123.

PMID:
12699252
16.
17.

Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.

Haimovici R, Kramer M, Miller JW, Hasan T, Flotte TJ, Schomacker KT, Gragoudas ES.

Curr Eye Res. 1997 Feb;16(2):83-90.

PMID:
9068937
18.

Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications.

Chen B, Pogue BW, Luna JM, Hardman RL, Hoopes PJ, Hasan T.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):917-23.

19.

Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy.

Lin GC, Tsoukas ML, Lee MS, González S, Vibhagool C, Anderson RR, Kollias N.

Photochem Photobiol. 1998 Oct;68(4):575-83.

PMID:
9796441
20.

Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor.

Chen B, Pogue BW, Goodwin IA, O'Hara JA, Wilmot CM, Hutchins JE, Hoopes PJ, Hasan T.

Radiat Res. 2003 Oct;160(4):452-9.

PMID:
12968929

Supplemental Content

Support Center